Axsome Therapeutics (AXSM) had the highest return between November 1, 2019 and December 7, 2019 by a US stock with a market cap of $2B+, returning 87.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Axsome Therapeutics (AXSM) | 11/1/2019 - 12/7/2019 | 87.42% |
Surgery Partners (SGRY) | 11/1/2019 - 12/7/2019 | 79.93% |
CleanSpark (CLSK) | 11/1/2019 - 12/7/2019 | 75% |
Bloom Energy (BE) | 11/1/2019 - 12/7/2019 | 73.68% |
Arrowhead Pharmaceuticals (ARWR) | 11/1/2019 - 12/7/2019 | 66.96% |
Xenon Pharmaceuticals (XENE) | 11/1/2019 - 12/7/2019 | 62.21% |
Ubiquiti Networks (UI) | 11/1/2019 - 12/7/2019 | 55.15% |
Nio Inc Class A ADR (NIO) | 11/1/2019 - 12/7/2019 | 51.68% |
Krystal Biotech (KRYS) | 11/1/2019 - 12/7/2019 | 51.27% |
PG&E (PCG) | 11/1/2019 - 12/7/2019 | 50.31% |
Vista Oil Gas ADR (VIST) | 11/1/2019 - 12/7/2019 | 48.59% |
Immunitybio (IBRX) | 11/1/2019 - 12/7/2019 | 47.66% |
BioNTech SE (BNTX) | 11/1/2019 - 12/7/2019 | 45.06% |
BridgeBio Pharma (BBIO) | 11/1/2019 - 12/7/2019 | 44.63% |
DexCom (DXCM) | 11/1/2019 - 12/7/2019 | 44.45% |
Alnylam Pharmaceuticals (ALNY) | 11/1/2019 - 12/7/2019 | 42.19% |
Crispr Therapeutics (CRSP) | 11/1/2019 - 12/7/2019 | 40.99% |
Merit Medical Systems (MMSI) | 11/1/2019 - 12/7/2019 | 40.03% |
Axon Enterprise (AXON) | 11/1/2019 - 12/7/2019 | 39.58% |
Synaptics (SYNA) | 11/1/2019 - 12/7/2019 | 39.44% |
Trupanion (TRUP) | 11/1/2019 - 12/7/2019 | 39.21% |
Sitime (SITM) | 11/1/2019 - 12/7/2019 | 38.69% |
Tenet Healthcare (THC) | 11/1/2019 - 12/7/2019 | 38.46% |
Qiagen (QGEN) | 11/1/2019 - 12/7/2019 | 37.17% |
Peloton Interactive (PTON) | 11/1/2019 - 12/7/2019 | 36.7% |
